ArticleThoracic cancer2024

Factors associated with prolonged progression-free survival of patients treated with first-line afatinib for advanced epidermal growth factor receptor-mutated non-small cell lung cancer.

Li-Chung Chiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.